During the past decade, Montgomery Rheumatology Associates conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Montgomery Rheumatology Associates" #1 collaborator was "The Cleveland Clinic" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Montgomery Rheumatology Associates" are "Rheumatoid Arthritis" (2 trials), "Arthritis, Rheumatoid" (1 trials), "Autoimmune Diseases" (1 trials), "Immunologic Diseases" (1 trials) and "Lupus Glomerulonephritis" (1 trials). Many other conditions were trialed in "Montgomery Rheumatology Associates" in a lesser frequency.

Most popular intervention types in "Montgomery Rheumatology Associates" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "MM-093" (2 trials), "Abetimus sodium (LJP 394)" (1 trials), "Diclofenac topical sodium gel 1%" (1 trials), "Ibuprofen" (1 trials) and "Naproxen" (1 trials). Other intervention names were less common.

The vast majority of trials in "Montgomery Rheumatology Associates" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Montgomery Rheumatology Associates". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Montgomery Rheumatology Associates, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Montgomery Rheumatology Associates, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".